Vermillion & White Wealth Management Group »

Kyverna Therapeutics shares owned by Vermillion & White Wealth Management Group

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Vermillion & White Wealth Management Group from 13F filings

Historical chart of Vermillion & White Wealth Management Group investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Vermillion & White Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Vermillion & White Wealth Management Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $10k 1.1k 9.40

More positions owned by Vermillion & White Wealth Management Group

Ishares Core S&p 500 Etf Uie (IVV)
Dimensional Intern Core Eqt Mkt Etf Uie (DFAI)
Dimensional Core Fixed Income Etf Uie (DFCF)
Astoria Us Quality Growth Kings Etf Uie (GQQQ)
Astoria Us Equal Wt Qlt Kings Etf Uie (ROE)
Dimensional Emerg Core Eqy Mrkt Etf Uie (DFAE)
Dimensional Shrt Drt Fxdincm Etf Uie (DFSD)
St Strt Spdr Prtfl Intdttm Tsry Etf Uie (SPTI)
Ea Astoria Dynmc Cre Us Fxd Incm Etf Uie (AGGA)
Invsc Kbw Bank Etf Uie (KBWB)
Astoria Real Assets Etf Uie (PPI)
Ishares Flexible Incme Active Etf Uie (BINC)
Microsoft Corporation (MSFT)
Apple (AAPL)
Doubleline Mortgage Etf Uie (DMBS)

View all positions for Vermillion & White Wealth Management Group

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Deerfield Management Company
Vanguard Group
AIGH Capital Management
Insight Holdings
Woodline Partners
Propel Bio Management
Mbb Public Markets I
Alyeska Investment Group
Millennium Management
BlackRock
RFG Advisory
Susquehanna International

View all funds holding Kyverna Therapeutics